Local Regulatory Experts
Connect with regulatory affairs consultancies specializing in this region.
Registrar Corp
維吉尼亞州漢普頓 (總部), 中國深圳, 英國倫敦, 法國巴黎, 西班牙馬德里, 印度海得拉巴, 馬來西亞吉隆坡, 以色列特拉維夫, 瓜地馬拉瓜地馬拉市, 南非開普敦
000 家企業處理 FDA 註冊、美國代理人要求、標籤合規及扣留協助等事務。我們提供包含 FDA 合規監控器 (Compliance Monitor) 和不良事件管理軟體在內的技術解決方案,協助食品、飲料、醫療器材、藥品和化妝品行業的企業應對複雜的法規環境。
MedEnvoy Global
荷蘭海牙, 英國倫敦, 美國, 瑞士, 澳洲
一家全球法規合規合作夥伴,專注於為醫療器材和 IVD 製造商提供在地代表(EC Rep、UKRP、CH Rep、美國代理人)和獨立進口商服務。我們協助企業應對歐洲、英國、瑞士和美國的複雜法規,同時保持供應鏈的靈活性。
KoBridge Co Ltd
韓國首爾, 瑞士洛桑
我們為需要應對日益複雜的全球法規的醫療器材製造商提供快速、有效和靈活的解決方案。他們的核心能力涵蓋 CE 標誌、FDA 510(k)/PMA、MDSAP,尤其是韓國 MFDS 註冊和 KGMP 合規性。他們處理主動、非主動、組合和動物源性設備,提供從策略規劃和文件準備到品質系統實施 (ISO 13485) 和稽核的服務。
IMed Consultancy Ltd
英國, 愛爾蘭
幫助醫療器械和體外診斷公司進行 CE 標記、品質管理系統、審計和全球註冊。
July 16, 2025
Approximately 5 minutes
Advertising Medicines in the United Kingdom: Rules and Best Practices
Advertising Medicines in the United Kingdom: Rules and Best Practices
1. Overview of advertising rules
In the UK, advertising of medicinal products is governed by specific legal requirements. You may advertise over-the-counter medicines, pharmacy medicines and general sales list products to the general public; however, prescription-only medicines (POMs) cannot be advertised to the public and may only be promoted to healthcare professionals or others who can prescribe or supply them. Any medicine must be licensed by the Medicines and Healthcare products Regulatory Agency (MHRA) or, for Northern Ireland under certain circumstances, by the European Commission to be advertised. You may only advertise a medicine in a territory where it is licensed. Source: Advertise your medicines ([GOV.UK][1])
2. Advertising to the public
When advertising to the general public, adverts must meet content requirements and must not:
- promote a use not covered by the product licence
- make misleading claims or suggest guaranteed effects or no side-effects
- imply that seeing a doctor or pharmacist isn’t necessary
- use endorsements from healthcare professionals or celebrities
- target children under 16 Additionally, the advert must include the medicine’s name, the active ingredient (if single), what it’s for, and an instruction to “always read the label” or accompanying leaflet. Source: Advertise your medicines ([GOV.UK][1])
3. Advertising to healthcare professionals and prescribers
Medicines including prescription-only medicines can be advertised to healthcare professionals or others who prescribe or supply the product. In these adverts, information must include:
- product name and active ingredients
- summary of the product’s characteristics such as dosage, method of use, contraindications and precautions
- the condition(s) the medicine treats This provision allows companies to communicate clinical details where appropriate to professional audiences. Source: Advertise your medicines ([GOV.UK][1])
4. Licensing and territorial considerations
You may only advertise a medicine where it holds a marketing authorisation. For UK-wide advertising, ensure the product is licensed in both Great Britain and Northern Ireland, and include details of both licences if separate. Advertising a medicine outside its licensed territory or without a valid licence is prohibited under UK law. Source: Advertise your medicines ([GOV.UK][1])
5. Comparison with advertising codes
UK advertising codes such as the CAP Code also reflect legal restrictions: prescription-only medicines may not be advertised to the public under rules like CAP Code 12.12, reinforcing statutory advertising bans and protecting public health by limiting direct-to-consumer promotion of POMs. Source: CAP Code – Prescription-only medicines ([asa.org.uk][2])
6. Supporting Guidance: the Blue Guide
Detailed procedural and content advice on advertising and promoting medicines is provided in the MHRA Blue Guide, which interprets the legal framework and offers best practice examples. This guidance should be consulted alongside the core advertisement rules when planning campaigns. Source: Blue Guide: advertising and promoting medicines ([GOV.UK][3])
7. Enforcement and compliance
Regulatory bodies such as the MHRA and the Advertising Standards Authority (ASA) enforce these rules. Advertisements for prescription-only medicines directed at the public are subject to investigation and enforcement action, with penalties for non-compliance. This reflects ongoing efforts to protect public health and ensure accurate medical information. Source: MHRA and partners reaffirm advertising rules ([GOV.UK][4])
Have a Question?
Ask our experts about this topic. We'll do our best to respond to your question.